Orpea SA (ORPEF)
USD 14.22
(0.0%)
USD 14.22
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4.02 Billion USD | 172.77% |
| 2022 | 1.47 Billion USD | -81.48% |
| 2021 | 7.96 Billion USD | 0.35% |
| 2020 | 7.93 Billion USD | 20.69% |
| 2019 | 6.57 Billion USD | 36.59% |
| 2018 | 4.81 Billion USD | 9.74% |
| 2017 | 4.38 Billion USD | 9.42% |
| 2016 | 4 Billion USD | 44.89% |
| 2015 | 2.76 Billion USD | 16.35% |
| 2014 | 2.37 Billion USD | 55.32% |
| 2013 | 1.53 Billion USD | 20.14% |
| 2012 | 1.27 Billion USD | 0.76% |
| 2011 | 1.26 Billion USD | -8.26% |
| 2010 | 1.37 Billion USD | 13.04% |
| 2009 | 1.21 Billion USD | 16.52% |
| 2008 | 1.04 Billion USD | 37.77% |
| 2007 | 759.93 Million USD | 175.28% |
| 2006 | 276.06 Million USD | 50.48% |
| 2005 | 183.45 Million USD | -7.99% |
| 2004 | 199.37 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 4.72 Billion USD | 17.47% |
| 2023 Q1 | 4.72 Billion EUR | -1.52% |
| 2023 FY | 4.54 Billion EUR | -5.44% |
| 2023 Q3 | 7.85 Billion EUR | 66.09% |
| 2023 Q2 | 1.57 Billion USD | 6.68% |
| 2023 Q4 | 5.01 Billion USD | 218.5% |
| 2022 Q2 | 8 Billion USD | 0.45% |
| 2022 FY | 4.8 Billion EUR | -51.85% |
| 2022 Q4 | 1.47 Billion USD | -81.56% |
| 2022 Q1 | 10.86 Billion EUR | 8.93% |
| 2022 Q3 | 4.8 Billion EUR | -55.8% |
| 2021 Q2 | 7.99 Billion USD | 0.71% |
| 2021 Q4 | 7.96 Billion USD | -0.36% |
| 2021 Q3 | 10.05 Billion EUR | 6.05% |
| 2021 FY | 9.97 Billion EUR | 8.34% |
| 2021 Q1 | 9.48 Billion EUR | 2.99% |
| 2020 Q4 | 7.93 Billion USD | 12.15% |
| 2020 FY | 9.2 Billion EUR | 13.37% |
| 2020 Q1 | 8.62 Billion EUR | 6.26% |
| 2020 Q2 | 7.07 Billion USD | 7.62% |
| 2020 Q3 | 9.4 Billion EUR | 9.04% |
| 2019 Q1 | 8.01 Billion EUR | 57.06% |
| 2019 Q2 | 6.62 Billion USD | 37.56% |
| 2019 FY | 8.12 Billion EUR | 59.09% |
| 2019 Q3 | 8.12 Billion EUR | 1.3% |
| 2019 Q4 | 6.57 Billion USD | -0.7% |
| 2018 Q2 | 4.49 Billion USD | 2.53% |
| 2018 Q3 | 5.1 Billion EUR | 7.87% |
| 2018 Q1 | 4.73 Billion EUR | 2.39% |
| 2018 FY | 5.1 Billion EUR | 10.45% |
| 2018 Q4 | 4.81 Billion USD | 7.03% |
| 2017 Q4 | 4.38 Billion USD | 22.62% |
| 2017 Q1 | 4.02 Billion EUR | 5.96% |
| 2017 FY | 4.62 Billion EUR | 21.58% |
| 2017 Q2 | 3.57 Billion USD | 10.8% |
| 2017 Q3 | 4.62 Billion EUR | 14.74% |
| 2016 Q3 | 3.8 Billion EUR | 7.04% |
| 2016 Q4 | 3.22 Billion USD | 11.73% |
| 2016 Q2 | 2.89 Billion EUR | 0.0% |
| 2016 FY | 3.8 Billion EUR | 18.09% |
| 2016 Q1 | 3.55 Billion EUR | 10.33% |
| 2015 Q1 | 2.57 Billion EUR | 4.06% |
| 2015 Q2 | 2.57 Billion EUR | 0.0% |
| 2015 Q3 | 3.21 Billion EUR | 24.78% |
| 2015 FY | 3.21 Billion EUR | 29.85% |
| 2015 Q4 | 3.21 Billion EUR | 0.0% |
| 2014 Q1 | 1.96 Billion EUR | 2.3% |
| 2014 FY | 2.47 Billion EUR | 28.78% |
| 2014 Q4 | 2.47 Billion EUR | 0.0% |
| 2014 Q3 | 2.47 Billion EUR | 25.89% |
| 2014 Q2 | 1.96 Billion EUR | 0.0% |
| 2013 Q1 | 1.68 Billion EUR | 0.98% |
| 2013 Q3 | 1.92 Billion EUR | 13.89% |
| 2013 Q4 | 1.92 Billion EUR | 0.25% |
| 2013 FY | 1.92 Billion EUR | 15.3% |
| 2013 Q2 | 1.68 Billion EUR | -0.0% |
| 2012 Q4 | 1.66 Billion EUR | 0.0% |
| 2012 FY | 1.66 Billion EUR | 14.2% |
| 2012 Q2 | 1.49 Billion EUR | 0.0% |
| 2011 FY | 1.46 Billion EUR | 0.22% |
| 2011 Q4 | 1.46 Billion EUR | 0.0% |
| 2011 Q2 | 1.48 Billion EUR | 0.0% |
| 2010 Q4 | 1.45 Billion EUR | 0.0% |
| 2010 FY | 1.45 Billion EUR | 23.59% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 Q2 | 1.05 Billion EUR | 0.0% |
| 2009 FY | 1.18 Billion EUR | 14.16% |
| 2009 Q4 | 1.18 Billion EUR | 0.0% |
| 2008 FY | 1.03 Billion EUR | 38.39% |
| 2007 FY | 747.04 Million EUR | 94.18% |
| 2006 FY | 384.71 Million EUR | 35.72% |
| 2005 FY | 283.46 Million EUR | 13.49% |
| 2004 FY | 249.76 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 1.82 Million USD | -220201.96% |
| Arem Pacific Corporation | 151.51 Thousand USD | -2655610.731% |
| Assisted 4 Living, Inc. | - USD | -Infinity% |
| BioCorRx Inc. | 3.89 Million USD | -103199.82% |
| Bionik Laboratories Corp. | 2.39 Million USD | -168240.57% |
| Banyan Corp. | 2.43 Million USD | -165386.868% |
| Clearday, Inc. | 25.8 Million USD | -15490.643% |
| Dental Patient Care America, Inc. | - USD | -Infinity% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | 1.93 Million USD | -208293.817% |
| First Choice Healthcare Solutions, Inc. | 1.28 Million USD | -313367.729% |
| Selectis Health, Inc. | 25.17 Million USD | -15882.195% |
| Ethema Health Corporation | 20.52 Thousand USD | -19608803.509% |
| HealthLynked Corp. | 450 Thousand USD | -894066.0% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | - USD | -Infinity% |
| JRSIS Health Care Corporation | 24.95 Thousand USD | -16127142.485% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 54.46 Million USD | -7287.239% |
| MedSmart Group Inc. | 50 Thousand USD | -8047394.0% |
| North America Frac Sand, Inc. | - USD | -Infinity% |
| Nova Leap Health Corp. | 914.05 Thousand USD | -440107.93% |
| Nexteligent Holdings, Inc. | - USD | -Infinity% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 6.89 Million USD | -58260.399% |
| Raffles Medical Group Ltd | 52.43 Million USD | -7573.6% |
| Ryman Healthcare Limited | 1.52 Billion USD | -164.318% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 57.07 Thousand USD | -7049334.994% |
| Mycotopia Therapies, Inc. | - USD | -Infinity% |
| U.S. NeuroSurgical Holdings, Inc. | 58 Thousand USD | -6937394.828% |
| Veltex Corporation | - USD | -Infinity% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | - USD | -Infinity% |